DNDi Webinar: Operational experience for COVID-19 vaccine trials: Lessons from the field, 17 March 2021
With over 80 COVID-19 vaccine candidates now in phase 1, 2 or 3 clinical trials, social, ethical and political questions continue to emerge. Whilst vaccine trials adhere to bioethics, their everyday ethics are negotiated in the field by frontline workers engaging with communities in specific local contexts. This is especially so when research elicits local concerns that are expressed through rumours, gossip, conspiracy theories and alternative explanatory models. Building good relations between researchers and communities requires engaging with these rumours, as they articulate local interpretations of medical research ethics.
In this webinar, the second in a series on social science research related to vaccine trials, attendees will hear from social science and community engagement experts who will draw on their experiences from clinical trials during COVID-19 and past epidemics. Speakers will share and discuss issues related to everyday ethical and practical challenges in community engagement work.
MODERATOR: Prof. Shelley Lees | London School of Hygiene and Tropical Medicine, UK
SPEAKERS:
• Mr Mahmood H. Bangura | University of Makeni & EBOVAC-Salone, Sierra Leone
• Ms Noni Mumba | KEMRI - Wellcome Trust Research Programme, Kenya
• Dr Malina Osman | Universiti Putra Malaysia, Malaysia
• Mr Benjamin Shukuru Kasiwa | World Vision & Université Libre des Pays des Grands Lacs, Democratic Republic of the Congo
For more information visit: https://zoom.us/webinar/register/3216057251193/WN_aTL854nuT9-jd2ADNO9YcQ
Articles
Virtual Workshop: Recognition And Control Of Mtb Infected Cells: From Basics To The Clinic | 13 – 14June 2023
The Stop
TB Partnership Working Group on New TB Vaccines (WGNV) and the National
Institute for Allergy and Infectious Diseases (NIAID)are
co-hosting a workshop on the topic of Recognition and Control of Mtb
Infected Cells: From Basics to the Clinic. This workshop is intended to address
the need for correlates and to identify platforms that measure recognition or
control of the infected cell - especially in humans - as identified in the EDCTP/AIGHD Global Roadmap for
Research and Development of New TB Vaccines and the Strategic Framework for
New TB Vaccines in the Stop TB Partnership Global Plan to End TB 2023 - 2030.
The overall goals of this workshop
are to:
- elucidate the mechanisms by
which the immune system recognizes the Mtb-infected cell
- explore the degree to which
such recognition can lead to control of the intracellular microbe, and
- discuss the translational
implications of these observations
The workshop format will be largely
discussion-based. Each session will have three short presentations that will
provide a high-level overview of key topics within the session theme, followed
by a discussion between the session chairs, speakers, and participants.
Click here
to view the programme and
speakers.
This workshop is free of charge and
open to any participants interested in this topic.
Ssi/Isid Infectious Diseases Research Fellowships | Deadline For Applications: 16 June 2023
The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
Ethical Review Of Decentralized Clinical Trials (Dcts): Tools, Resources & Best Practices.
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here